Watkins L L, Grossman P, Sherwood A
Lown Cardiovascular Research Foundation, Brookline, Mass 02146, USA.
Hypertension. 1996 Aug;28(2):238-43. doi: 10.1161/01.hyp.28.2.238.
In this study, we examined the sensitivity of two recently developed noninvasive baroreflex measurement techniques to assess baroreflex control in hypertension. We assessed baroreflex sensitivity noninvasively from covariations of systolic pressure and RR interval using spectral analysis and sequence detection. The noninvasive estimates of baroreflex control were compared with estimates derived from phenylephrine-induced increases in systolic pressure and RR interval in normotensive subjects (n = 27) and borderline hypertensive subjects (n = 15). Baroreflex sensitivity was significantly reduced in the borderline hypertensive group relative to the normotensive group when assessed with the use of either the noninvasive or invasive methods to index baroreflex control. In addition, estimates obtained from the noninvasive methods were significantly correlated with baroreflex sensitivity assessed with the phenylephrine method (spectral: r = .48, P < .001; sequence: r = .50, P < .001). These findings suggest that spectral analysis and the sequence method provide viable alternatives to the pharmacological approach for estimation of baroreflex sensitivity in hypertension.
在本研究中,我们检测了两种最近开发的无创压力反射测量技术评估高血压患者压力反射控制的敏感性。我们使用频谱分析和序列检测,通过收缩压与RR间期的协变关系对压力反射敏感性进行无创评估。将无创压力反射控制评估结果与通过去氧肾上腺素使正常血压受试者(n = 27)和临界高血压受试者(n = 15)的收缩压及RR间期升高而得出的评估结果进行比较。当使用无创或有创方法来衡量压力反射控制时,临界高血压组的压力反射敏感性相对于正常血压组显著降低。此外,无创方法得出的评估结果与用去氧肾上腺素法评估的压力反射敏感性显著相关(频谱分析:r = 0.48,P < 0.001;序列检测:r = 0.50,P < 0.001)。这些结果表明,频谱分析和序列检测方法为评估高血压患者压力反射敏感性提供了替代药理学方法的可行选择。